Clinical trials
Completed Phase 1/2 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Kiadis Pharma | 2 |
| M.D. Anderson Cancer Center | 2 |
| Pharmacyclics LLC. | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Biocon Limited | 1 |
| Cambium Bio Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 37 |
| Leukemia | 9 |
| Bronchiolitis Obliterans Syndrome | 8 |
| Leukemia, Myeloid, Acute | 6 |
| Myelodysplastic Syndromes | 6 |
| Hematologic Neoplasms | 5 |
| Lymphoma | 5 |
| Multiple Myeloma | 4 |
| Blast Crisis | 3 |
| Hodgkin Disease | 3 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.